The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst ...
Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...
The Chief Executive of US pharmaceutical company Eli Lilly says it will be hard to come back from this moment.
Lilly, a sweet and social 1-year-old old terrier with a lot of positive qualities, is available for adoption at The Cat House ...
Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...
Arrowstreet Capital Limited Partnership decreased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 99.1% during the 4th quarter, according to the company in its most recent filing ...
But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...
Killeen ISD has reported that Dr. Frederick Lilly submitted a resignation letter as the principal of Roy J. Smith Middle ...
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.
Dazia Lawrence had the chance to represent the University of Kentucky one last time, competing in the Lilly women's college ...
Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in ...
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results